[{"indications": "Indications\u00a0see under Dose", "name": "RIFABUTIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.9 Antituberculosis drugs", "RIFABUTIN"], "cautions": "Cautions\u00a0see under Rifampicin; acute porphyria (section 9.8.2)", "side-effects": "Side-effects\u00a0nausea, vomiting; leucopenia, thrombocytopenia,\r\nanaemia, rarely haemolysis; raised liver enzymes, jaundice, rarely\r\nhepatitis; uveitis following high doses or administration with drugs\r\nwhich raise plasma concentration\u2014see also interactions: Appendix 1 (rifamycins); arthralgia, myalgia, influenza-like syndrome,\r\ndyspnoea; also hypersensitivity reactions including fever, rash, eosinophilia,\r\nbronchospasm, shock; skin, urine, saliva and other body secretions\r\ncoloured orange-red; asymptomatic corneal opacities reported with\r\nlong-term use", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/14339.htm", "doses": ["Prophylaxis of Mycobacterium\r\navium complex infections in immunosuppressed patients with\r\nlow CD4 count (see product literature), 300\u00a0mg daily as a single dose", "Treatment of non-tuberculous mycobacterial disease, in combination\r\nwith other drugs, 450\u2013600\u00a0mg daily as a single dose for up to 6 months\r\nafter cultures negative", "Treatment of pulmonary tuberculosis, in combination with other\r\ndrugs, 150\u2013450\u00a0mg daily as a single dose for at least 6 months", "child not recommended"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid\u2014no information available"}]